Sara Jaume-Perez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Safety of Acupuncture Using Semi-Permanent Needles in a Pediatric Cancer Unit: A Retrospective Study.

Safety of Acupuncture Using Semi-Permanent Needles in a Pediatric Cancer Unit: A Retrospective Study.

Journal: Integrative cancer therapies

Published: May 19, 2026

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio-Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse.

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio-Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse.

Journal: Pediatric blood & cancer

Published: April 27, 2025

Childhood Cancer Survivors in Latin America: Insights Into Health Outcomes and Information Needs.

Childhood Cancer Survivors in Latin America: Insights Into Health Outcomes and Information Needs.

Journal: Pediatric blood & cancer

Published: March 09, 2025

Patient Acceptability of the First Integrative Pediatric Oncology Unit in Spain-The Pediatric Cancer Center Barcelona Experience: A Retrospective Study.

Patient Acceptability of the First Integrative Pediatric Oncology Unit in Spain-The Pediatric Cancer Center Barcelona Experience: A Retrospective Study.

Journal: Cancers

Published: December 11, 2024

KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma.

KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma.

Journal: Cancer research

Published: October 08, 2024

Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy.

Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy.

Journal: Cancers

Published: April 09, 2024

Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects.

Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects.

Journal: Frontiers in oncology

Published: February 08, 2024

Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes.

Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes.

Journal: Pediatric blood & cancer

Published: January 27, 2024

DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1.

DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1.

Journal: Heliyon

Published: September 04, 2023

Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes.

Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes.

Journal: Cancers

Published: August 24, 2023

Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma.

Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma.

Journal: Pediatric blood & cancer

Published: July 28, 2023

Vitamin D Status in Children With High-risk Neuroblastoma.

Vitamin D Status in Children With High-risk Neuroblastoma.

Journal: Journal of pediatric hematology/oncology

Published: May 03, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026